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Abstract 
Purpose Sevoflurane increases reactive oxygen species (ROS) which mediate 
cardioprotection against myocardial ischemia-reperfusion injury. Emerging evidence 
suggests that autophagy is involved in cardioprotection. We examined whether reactive 
oxygen species mediate sevoflurane preconditioning through autophagy. 
Methods  Isolated guinea pigs hearts were subjected to 30 min ischemia followed by 120 
min reperfusion (control). Anesthetic preconditioning was elicited with 2% sevoflurane for 
10 minutes prior to ischemia (SEVO). The ROS-scavenger, n-(2-mercaptopropionyl) 
glycine (MPG, 1mmol/L) was administered starting 30 min before ischemia to sevoflurane-
treated (SEVO+MPG) or non-sevoflurane-treated (MPG) hearts. Infarct size was determined 
by triphenyltetrazolium chloride stain. Tissue samples were obtained after reperfusion to 
determine autophagy-related protein (microtubule-associated protein light chain I and II: 
LC3-I, II) and 5’AMP-activated protein kinase (AMPK) expression using Western blot 
analysis. Electron microscopy was used to detect autophagosomes. 
Results Infarct size was significantly reduced and there were more abundant 
autophagosomes in SEVO compared with control. Western blot analysis revealed that the 
ratio of LC3-II/I and phosphorylation of AMPK were significantly increased in SEVO. 
These effects were abolished by MPG. 
Conclusions Sevoflurane induces cardioprotection through ROS-mediated upregulation of 
autophagy. 
 
180 words 
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Introduction 
Sevoflurane is a popular anesthetic with few clinical side effects and is used 
worldwide. Over the last 15 years, experimental [1-5] and clinical studies [6] have 
demonstrated that volatile anesthetics, including sevoflurane, exert cardioprotective effects 
against myocardial ischemia-reperfusion injury such as ischemic preconditioning where brief 
episodes of ischemia and reperfusion before prolonged ischemia dramatically limit infarct 
size [7]. Many potential mechanisms for this cardioprotection known as anesthetic 
preconditioning (APC) have been proposed [8]. Novalija et al. demonstrated that APC by 
sevoflurane is initiated by reactive oxygen species (ROS) produced during sevoflurane 
exposure and reduces the burst formation of ROS after ischemia-reperfusion in isolated 
guinea pig hearts [9]. Recently, cardioprotection by sevoflurane has been shown to be 
mediated by ROS-induced 5’ AMP-activated protein kinase (AMPK) activation which is a 
well known regulator of cellular energy status [10]. 
AMPK is a key enzyme for the initiation of autophagy which is a tightly regulated 
intracellular catabolic process for the disposal of damaged and dysfunctional organelles and 
protein aggregates to maintain homeostasis [11]. Growing evidence suggests that autophagy 
is activated during various pathological conditions, including myocardial ischemia-
reperfusion injury [12]. It has been reported that excessive activation of autophagy can be 
detrimental and may even lead to cell death called autophagic cell death [13]. In contrast, 
Sala-Mercado et al. demonstrated that pre-ischemic induction of autophagy limits 
myocardial infarct size in in vivo swine hearts [14]. Qiao et al. demonstrated that 
cardioprotection of delayed preconditioning by sevoflurane is mediated by upregulation of 
autophagy [15]. However, it has not been determined whether activation of autophagy is 
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beneficial or detrimental in myocardial ischemia-reperfusion injury. Although ROS mediate 
sevoflurane preconditioning, it is not known whether autophagy is involved in this ROS-
induced cardioprotection. Thus, we hypothesized that ROS produced during sevoflurane 
exposure mediates sevoflurane cardiac preconditioning through activation of autophagy. 
Elucidating the role of autophagy in sevoflurane preconditioning could prove clinically 
useful in patients at cardiovascular risk during perioperative periods.  
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Materials and Methods  
This study was conducted in accordance with the Guidelines for Animal Research at 
Osaka Dental University, and with the approval of the Animal Experiment Committee of 
Osaka Dental University, Osaka, Japan. These guidelines conform to those laid out in the 
Guide for the Care and Use of Laboratory Animals, available from the National Academy of 
Science. Male Hartley guinea pigs were fed Lab Diet (RC4, Oriental Yeast, Tokyo, Japan) 
and given water ad libitum. A ROS-scavenger, n-(2-mercaptopropionyl) glycine (MPG) was 
purchased from Sigma Aldrich (Ann Arbor, MI, USA). 
 
Isolated Heart Perfusion and Measurement of Function 
Male guinea pigs weighing 550-700g (12-13 weeks old) were given heparin (1000 
units intraperitoneally), then anesthetized with pentobarbital (60 mg/kg, intraperitoneally). 
Hearts were excised and immediately arrested in cold iso-osmotic saline containing 20 mM 
KCl. The aorta was cannulated and the isolated hearts were perfused at 70 mmHg on a 
nonrecirculating isovolumic perfused heart apparatus, using a Krebs-Henseleit perfusate and 
paced at 240 beats/min as previously described [3]. Left ventricular developed pressure 
(LVDP; mmHg) was measured using a 2.5 French, high-fidelity micromanometer (Nihon-
Kohden, Tokyo, Japan) passed into a compliant latex balloon, inserted into the left ventricle, 
and recorded on a PowerLab 2/20 Data Recording System (ADInstruments, Hayward, 
Australia). The balloon was connected to a Y-adapter with one end used to advance the 
micromanometer and the other used to fill the left ventricular balloon with bubble-free water 
to an end-diastolic pressure (LVEDP) of 10 mmHg. Coronary flow (CF) (ml/min) was 
measured by collecting effluent. Global ischemia was achieved by clamping the aortic 
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inflow line. During ischemia, hearts were maintained at 37 °C by enclosure in a water-
jacketed air chamber. Warmed perfusate kept in the lower part of the chamber saturated the 
air with humidity and prevented cooling by evaporation. Heart temperature was 
continuously monitored by a digital thermometer (PTW-100A, Unique Medical, Tokyo, 
Japan). Sevoflurane was insufflated by passing the 95%O2/5%CO2 gas mixture through a 
calibrated vaporizer (ACOMA, Tokyo, Japan).  
 
Measurement of sevoflurane concentration 
Samples of coronary perfusate were collected anaerobically from the aortic cannula 
for measurement of sevoflurane concentration by an organic vapor sensor (OSP, Saitama, 
Japan). The organic vapor sensor is designed to detect volatile organic compounds (VOC) in 
the air. Prior to measurement of sevoflurane concentration, calibration of the organic vapor 
sensor was performed to make a standard VOC (ppm)-sevoflurane (mmol/L) curve. The 
concentration of sevoflurane was determined using the well described headspace method 
[16]. The vial (150ml) containing perfusate obtained from aortic cannula with closed air 
space in upper portion (headspace) was shaken for one minute. After reaching equilibration 
in the vial, the organic vapor sensor was connected to the vial to measure VOC (ppm) in the 
closed air space. The obtained data (ppm) were converted to the concentration of 
sevoflurane in the perfusate (mmo/L) using a standard VOC-sevoflurane curve. This 
concentration correlates well with that measured by the headspace method with gas 
chromatography which is usually used to measure sevoflurane concentration. 
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Experimental Protocol 
Animals were assigned to one of 4 groups (n=8 each; Figure 1). After a 20 min 
equilibration, baseline LVDP, LVEDP and CF were recorded. Hearts were subjected to 30 
min (control; CTL) of ischemia followed by 120 min of reperfusion. Anesthetic 
preconditioning was elicited by administration of sevoflurane (2%) for 10 min followed by 
10 min washout before 30 min (SEVO). A ROS-scavenger, MPG (1 mmol/L) was 
administered starting 30 min before ischemia in sevoflurane-treated (SEVO+MPG) or non-
sevoflurane-treated animals (MPG) hearts. MPG was dissolved in distilled water and was 
added to the Krebs-Henseleit perfusate to a final concentration of 1mmol/L.  
 
Determination of Myocardial Infarct Size 
At the end of experiments, hearts were quickly frozen at –80 °C for 15 min, and then 
sliced into 2 mm thick transverse sections from apex to base (6 slices/heart). After removing 
the right ventricle and defrosting, each slice was weighed and incubated at 37 °C with 1% 
triphenyltetrazolium chloride (Sigma Chemicals) in phosphate buffer (pH 7.4) for 10 min 
and then fixed in 10% formalin for at least 5 h to distinguish red stained viable tissue from 
pale unstained necrotic tissue [17]. Each slice was photographed and the necrotic area was 
determined using Adobe Photoshop
®
 CS (Adobe, San Jose, CA, USA) and multiplied by the 
weight of the slice, then expressed as a fraction of the left ventricle.  
 
Western Blot Analysis 
     Separate experiments were performed (n=4 for each group) to examine expression of 
autophagy-related protein (microtubule-associated protein light chain I and II: LC3-I, II), and 
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AMPK. Myocardial tissue samples were collected after 120min reperfusion, and homogenized 
in ice-cold homogenizing buffer containing 250 mM sucrose, 20 mM HEPES (pH 7.5), 10 
mM KCl, 2 mM EGTA, 2 mM MgCl2, 25 mM  NaF, 50 mM -glycerophosphate, 1 mM 
Na3VO4, 1mM PMSF and protease inhibitor leupeptin (10 g/ml). The homogenate was 
centrifuged at 1000g for 5 min at 4 °C to clean up. The supernatant was re-centrifuged at 
10000g for 15 min at 4 °C to obtain cytosolic fraction. The protein concentration was 
estimated with a Bradford assay. Equivalent amounts (20 g) of protein samples were loaded 
and separated on a 10% SDS-PAGE gradient gel, then electrically transferred overnight to a 
polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA, USA). After blocking with 5% 
skim milk in Tris-buffered saline containing 0.1% Tween-20 (TBS-T), the membranes were 
incubated for 2 h at 4 °C in TBS-T containing 5% skim milk and overnight 1:1000 dilution of 
rabbit primary antibody for LC3 (Medical & Biological Laboratories Co LTD, MA, USA), 
phospho AMPKα (Thr172) and total AMPK (Cell Signaling TECHNOLOGY, Boston, MA, 
USA). Membranes were incubated with a 1:1000 dilution of horseradish peroxidase–labeled 
anti-rabbit immunoglobulin G (NA 934V, GE Healthcare, Buckinghamshire, United 
Kingdom). The same blot was stripped and re-blotted with antibodies to α-tubulin (Santa Cruz 
Biotechnology) (to confirm equal protein loading). Bound antibody signals were detected with 
enhanced chemiluminescence (Pierce Biotechnology, Rockford, IL) and visualized using 
VersaDoc 5000 Imaging System (Bio-Rad, Hercules, CA, USA). Quantitative analysis of the 
band densities was performed by Quantity One software (Bio-Rad), and the results are 
presented as the ratio of phospho AMPK to total AMPK. The average light intensity was 
multiplied by 100 to facilitate presentation of an x-fold increase.  
 
Electron Microscopy 
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To confirm the induction of autophagy, cardiac specimens were obtained at 120 min 
of reperfusion (n=4 for each group). They were fixed with phosphate-buffered 2.5 % 
glutaraldehyde (pH 7.4) and were postfixed with 1 % osmium tetroxide, after which they 
were conventionally prepared for transmission electron microscopy (H-800, Hitachi, Tokyo, 
Japan). We performed a morphometric analysis under an electron microscope using the 
method described previously [18]. with some modification. In brief, a uniform sampling of 
electron micrographs was used for the morphometric assay of each group. Ten random fields 
micrographed at 6,000 from each of three blocks were printed at a final magnification of 
15,000 and analyzed on composite grids as described previously to calculate the density of 
autophagic vacuoles (number/100 m2), i.e., both autophagosomes and autolysosomes, 
within a cardiomyocyte. 
 
Statistical Analysis 
All data are expressed as meanSD. Statistical power analysis revealed that a sample 
size of n=8 would provide sufficient power (0.8) to detect a difference between mean infarct 
size indices of 15 % (SD=9, α=0.05). A group size of n=4 was used for Western blot to 
provide a power of 0.8 to detect a difference between means of 20% (SD=10, α=0.05). 
Hemodynamic data were tested for normal distribution and subsequently analyzed by a two-
factor repeated-measures analysis of variance for time and treatment. If an overall difference 
between the variables was observed, comparisons were performed as one-way ANOVA 
followed by Tukey's post-hoc test for inter-group differences and by Dunnett's for intra-
group differences with baseline values as the reference time point. Analyses of infarct size 
and Western blot were performed using one-way ANOVA followed by Student's t-test with 
Bonferroni's correction for multiple comparisons to avoid type I error. For changes within 
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and between groups a two-tailed p value less than 0.05 was considered significant in 
advance. (SPSS17 for Windows, SPSS Japan, Tokyo, Japan).  
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Results 
Of a total of 66, one heart in SEVO+MPG was not used secondary to intractable 
ventricular fibrillation after reperfusion and one heart was not used due to aortic rupture. 
Additional hearts were studied until each group had n=8 successful experiments for the 
infarct size study. There was no significant difference in body weight among groups. The 
concentration of sevoflurane in the coronary perfusate after 10 min of exposure was 
0.25±0.02 mM. Sevoflurane was not detected in the effluent during the baseline, ischemic, 
and reperfusion periods.  
 
Hemodynamics   
Hemodynamic data are shown in Table 1. Baseline LVDP and CF were similar 
among the 4 groups. Treatment of sevoflurane and/or MPG did not significantly change 
LVDP, LVEDP and CF before ischemia. Recovery of LVDP was significantly greater in 
SEVO, MPG and SEVO+MPG compared with CTL throughout reperfusion period. After 
120 min reperfusion, SEVO had significantly lower LVEDP compared to other groups. 
There was no significant difference in CF among all the groups throughout the experiment. 
This suggests that changes in CF could not account for the improved contractile recovery of 
the SEVO, MPG and SEVO+MPG groups.         
 
Myocardial Infarct Size 
Myocardial infarct size data are shown in Figure 2. Myocardial infarct size in SEVO 
was significantly reduced by approximately 50% compared with CTL hearts (SEVO: 25±8% 
vs. CTL: 48±6%, p<0.05). This cardioprotection achieved by sevoflurane was abolished by 
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MPG (SEVO: 25±8% vs. SEVO+MPG: 36±10%, p<0.05). Treatment with MPG alone 
decreased the infarct size compared with CTL (MPG: 39±8% vs. CTL: 48±6%, p<0.05).  
 
Electron Microscopy 
Figure 3 shows representative electron microphotographs of each study group. 
Although autophagic vacuoles were abundantly seen in cardiomyocytes from the untreated 
control heart (panel A: CTL), typical autophagosomes containing intracellular organelles, 
such as mitochondria and membrane-like structures (arrows), were even more increased after 
sevoflurane administration (panel B: SEVO). Autophagosomes were apparently diminished 
by addition of MPG (panels C and D: MPG and SEVO+MPG). Morphometric analysis of 
autophagosome density confirmed the above findings (Figure 3E). 
 
Western Blot analysis 
  LC3-I, II, total AMPK and the phosphorylation state of AMPK after treatment with 
sevoflurane and MPG are illustrated by a representative Western blot in Figure 4A. In hearts 
pretreated with sevoflurane, myocardial expression of LC3-II was increased compared with 
control hearts. This increased expression of LC3-II was abolished by administration of MPG 
(Figure 4B). The ratio of phospho AMPK to total AMPK was significantly increased in 
SEVO compared with CTL (Figure 4C). This increase was not caused by unequal loading of 
the western blot, as shown by the detection of α-tubulin. The combination of sevoflurane and 
MPG abolished this increased expression in SEVO.  
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Discussion 
This study demonstrated that ROS produced during sevoflurane exposure play a role 
in sevoflurane-induced cardioprotection through autophagy. Growing evidence suggests that 
ROS and autophagy are involved in cardioprotection by ischemic and volatile anesthetics 
preconditioning. The present study for the first time showed between link of these two 
mediators in sevoflurane-induced cardioprotection.  
It was well documented that a burst ROS formation during the very early reperfusion 
period after myocardial ischemia-reperfusion causes serious damage to cardiomyocytes [19]. 
Scavenging ROS has been shown to attenuate myocardial reperfusion injury [20]. This is 
consistent with the present study demonstrating that treatment with MPG alone before 
ischemia reduced infarct size compared with control. MPG is a highly diffusible low 
molecular weight compound that scavenges superoxide and hydroxyl radicals produced both 
intra- and extracellularly [21,22]. In contrast, a low level of ROS was reported to function as 
a protective second messenger during ischemic preconditioning [23]. It has been shown that 
APC by sevoflurane is triggered by production of ROS during the preconditioning period 
[24]. In turn, this generation of ROS reduces the burst production of ROS during the very 
early reperfusion period, which results in reduction of myocardial infarct size. In the present 
study, administration of MPG to sevoflurane-treated hearts abolished the infarct size limiting 
effect of sevoflurane preconditioning. This suggests that production of ROS during 
sevoflurane exposure plays an important role in sevoflurane preconditioning.  
There were no significant differences in LVDP and LVEDP among groups at 120 
min of reperfusion (e.g. SEVO vs. MPG or SEVO+MPG) despite the difference in infarct 
size. A possible reason for this discrepancy may be due to stunning caused by global 
  
 
15 
ischemia in a much greater area than the infarcted area of LV. Cohen et al. demonstrated that 
the enhanced functional recovery resulting from infarct size reduction by preconditioning 
becomes apparent 1 to 3 days later because of stunning [25]. 
Autophagy is a bulk degradation process in which cytosolic proteins and organelles 
are degraded through lysosomes. This is an evolutionally conserved process crucial for 
normal tissue homeostasis. Accumulating evidence suggests that autophagy is stimulated by 
ischemia and actually contributes to cardiomyocyte survival [26,27]. A recent study has 
shown that autophagy induced by ischemic preconditioning is essential for cardioprotection 
[28]. McCormick et al. demonstrated that enhancing autophagy confers protection against 
ischemia-reperfusion injury in cardiomyocytes [29]. Using in vivo swine models, Sala-
Mercado et al. showed that induction of autophagy by chloramphenicol succinate before 
ischemia limited infarct size [14]. However, it is not known whether this upregulation of 
autophagy is mediated by ROS produced during sevoflurane exposure. Recently, Dai et al. 
demonstrated that mitochondrial oxidative stress mediates induction of autophagy in 
angiotensin-II treated mouse hearts [30]. Hariharan et al. have shown that oxidative stress 
stimulates autophagic flux during myocardial ischemia-reperfusion [31]. In the present study, 
electron microscopy demonstrated that there were more abundant autophagosomes in 
sevoflurane-treated hearts than control. This upregulation of autophagy was abolished by 
MPG. Furthermore, western blot analysis showed that the ratio of LC3 II/I (a marker of 
autophagy) and phosphorylation of AMPK were increased in sevoflurane preconditioning, 
which was abolished by MPG. Both LC3 and AMPK are key enzymes for formation of 
autophagosomes. Cardiac AMPK activation has been shown to be linked to inhibition of 
GSK3β [32] which is a critical mediator of cardioprotection by APC [5]. This suggests that 
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ROS produced during sevoflurane exposure induced upregulation of autophagy in 
sevoflurane preconditioning.  
The following study limitations should be acknowledged. The isolated Langendorff 
perfused heart perfusion may not completely reflect the conditions in vivo. However, the ex 
vivo conditions of the present study were designed to exclude possible confounding systemic 
hemodynamic and humoral effects of sevoflurane. Although we did not directly measure 
ROS during sevoflurane exposure, the dose (1 mM) of MPG used in the present study has 
been shown to abolish the infarct size limiting effect of sevoflurane preconditioning [10]. 
In conclusion, sevoflurane exerts a cardioprotection against ischemia-reperfusion 
injury by ROS-mediated upregulation of autophagy. A more thorough understanding of the 
multiple signaling steps and the ultimate cytoprotective mechanisms underlying APC may 
lead to improvements in the management of patients at risk during perioperative periods. 
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Figure Legends  
Figure 1: Schematic illustration of the experimental protocol. There were 4 groups. After 20 
min baseline period, isolated perfused hearts were subjected to 30 min global ischemia and 
120 min reperfusion. Anesthetic preconditioning was elicited by administration of 10 min of 
SEVO (2%) with 10 min washout before 30 min ischemia. MPG was administered starting 
30 min before ischemia in hearts from SEVO-treated or non-SEVO-treated animals. Tissue 
samples were obtained after reperfusion. CTL, control; MPG, n-(2-mercaptopropionyl) 
glycine; SEVO, sevoflurane. 
 
Figure 2: Infarct size as a percentage of left ventricle in 4 groups. After 120min reperfusion, 
infarct size was significantly reduced in SEVO compared to CTL. This cardioprotection of 
SEVO was abolished by MPG. MPG alone decreased infarct size compared to CTL. Data are 
presented as mean ± SD; *p<0.05 versus CTL; †p<0.05 versus MPG and SEVO+MPG. CTL, 
control; MPG, n-(2-mercaptopropionyl) glycine; SEVO, sevoflurane (n=8 for each group). 
 
Figure 3: Electron microphotographs of cardiomyocytes. Autophagic vacuoles were seen in 
cardiomyocytes from the untreated control (panel A). Typical autophagosomes containing 
intracellular organelles, such as mitochondria and membrane-like structures (arrows), were 
more increased after sevoflurane administration (panel B: SEVO). Autophagosomes were 
apparently diminished by addition of MPG (panels C and D: MPG and SEVO+MPG). (E) 
Graph showing the density of autophagic vacuoles (number/100 m2) within a 
cardiomyocyte in each group. 
†
p<0.05 versus other groups.  Nucl, nucleus. Bars, 1 m. CTL, 
control; MPG, n-(2-mercaptopropionyl) glycine; SEVO, sevoflurane 
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Figure 4: (A) Representative western blot analysis of LC3-I, II, phosphorylated AMPK and 
total AMPK from left ventricular samples obtained after 120 min of reperfusion. (B) The 
ratio of LC3-II to LC3-I (LC3-II/I) was increased in SEVO compared to CTL. 
Administration of MPG abolished this increased LC3-II/I in the SEVO group. *p<0.05 
versus CTL. 
†
p<0.05 versus MPG and SEVO+MPG. (C) Densitometric evaluation of four 
experiments as the x-fold increase in average light density vs. CTL. The results are presented 
as the ratio of the phosphorylated AMPK to total AMPK. The average light intensity was 
multiplied by 100 to facilitate the presentation of an x-fold increase. Data are presented as 
mean ± standard deviation. *p<0.05 versus CTL. 
†
p<0.05 versus MPG and SEVO+MPG. 
AMPK, 5’AMP-activated protein kinase; CTL, control; LC3-I, II, microtubule-associated 
protein light chain I and II; MPG, n-(2-mercaptopropionyl) glycine; SEVO, sevoflurane. 
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Table 1 
 
 
 
 TABLE 1. Hemodynamic Variables 
  
Baseline 
 After 
treatment 
(SEVO/MPG) 
 
Before 
ischemia 
 Reperfusion (min)  
   
 
 30 60 120 
LVDP (mmHg)                         
     CTL 113 ± 15  117 ± 13  116 ± 13  39 ± 7  34 ± 9  26 ± 6  
     SEVO 101 ± 13  100 ± 12  103 ± 12  63 ± 7*  60 ± 8*  52 ± 8*   
     MPG 113 ± 22  107 ± 23  104 ± 24  46 ± 19*  48 ± 15*  48 ± 9*  
   SEVO+MPG 102 ± 17  108 ± 21  110 ± 21  51 ± 18*  50 ± 17*  46 ± 16*  
LVEDP(mmHg)                         
     CTL 10 ± 0  11 ± 2  11 ± 2  50 ± 10  55 ± 15  57 ± 15  
     SEVO 10 ± 0  10 ± 3  10 ± 2  24 ± 7*    23 ± 4*   23  ± 5*  
     MPG 10 ± 0  11 ± 7  11 ± 7  48 ± 26  48 ± 25  40 ± 26  
     SEVO+MPG 10 ± 0  6 ± 6  6 ± 6  39 ± 16  36 ± 16  35 ± 18*  
CF (mL/min)                         
     CTL 27 ± 6  28 ± 6  28 ± 6  20 ± 4   19 ± 4   18 ± 4   
     SEVO 32 ± 8  28 ± 5  27 ± 5  22 ± 4   21 ± 5   21 ± 5   
     MPG 30 ± 9  30 ± 9  29 ± 8  22 ± 6  20 ± 6  19 ± 7  
     SEVO+MPG 26 ± 5  26 ± 5  27 ± 4  21 ±   7  18 ±   6  16 ± 6  
Data are presented as mean ± SD. LVDP=left ventricular developed pressure; LVEDP=left ventricular end-
diastolic pressure; CF=coronary flow; CTL=control; MPG=N-2-mercaptopropionyl glycine; 
SEVO=sevoflurane;. *p<0.05 vs. CTL,
 
 n=8 for each group. 
